Literature DB >> 17724183

Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye.

Maria J González-García1, Arancha González-Sáiz, Beatriz de la Fuente, Antonio Morilla-Grasa, Agustin Mayo-Iscar, Julio San-José, Jesus Feijó, Michael E Stern, Margarita Calonge.   

Abstract

PURPOSE: Adverse environmental conditions elicit dry eye (DE)-related signs and symptoms. The purpose of this work is to determine whether these conditions can alter a normal-to-borderline ocular surface in subjects with DE symptoms.
METHODS: Ten minimally symptomatic contact lens (CL)-wearing subjects were exposed, without (WO-) and with (W-)CLs, to a controlled adverse environment (CAE) of 22.0 +/- 2.0 degrees C and 19.0% +/- 4.0% relative humidity (RH) for 2 hours in an environmental chamber (EC). One month later, the same subjects were placed in an indoor normal environment (INE) of 24.2 +/- 1.3 degrees C and 34.8% +/- 2.9% RH for 2 hours. DE-related signs and symptoms were evaluated before and after each exposure. The reversibility of changes provoked by CAE or INE was also evaluated.
RESULTS: Without CL wear, significant changes were found in DE signs (noninvasive tear break-up time [NIBUT], conjunctival hyperemia and phenol red thread test) after CAE exposure, but not found after INE exposure. However with CL wear, the same tests were altered after both CAE and INE exposure. Most of these changes returned to normal values within 1 month after environmental exposure.
CONCLUSIONS: Significant changes in comfort and the ocular surface tests were found after 2 hours of exposure to CAE. These results show the negative impact that an adverse environment, especially low RH, can have on the ocular surface. These alterations were fully reversible. This indicates that the CAE is a safe and functional condition in which to standardize DE diagnostic tests and evaluate therapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724183     DOI: 10.1167/iovs.06-0817

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Factors predicting the ocular surface response to desiccating environmental stress.

Authors:  Anastasia Alex; Austin Edwards; J Daniel Hays; Michelle Kerkstra; Amanda Shih; Cintia S de Paiva; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-07       Impact factor: 4.799

Review 2.  Effects of Aging in Dry Eye.

Authors:  Cintia S de Paiva
Journal:  Int Ophthalmol Clin       Date:  2017

Review 3.  Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.

Authors:  Marjan Farid; Anshu Agrawal; Daniel Fremgen; Jeremiah Tao; He Chuyi; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Ocul Immunol Inflamm       Date:  2014-12-23       Impact factor: 3.070

4.  Assessing the Risk Factors For Diagnosed Symptomatic Dry Eye Using a Smartphone App: Cross-sectional Study.

Authors:  Ngamjit Kasetsuwan; Olan Suwan-Apichon; Kaevalin Lekhanont; Varintorn Chuckpaiwong; Usanee Reinprayoon; Somporn Chantra; Vilavun Puangsricharern; Lalida Pariyakanok; Pinnita Prabhasawat; Nattaporn Tesavibul; Winai Chaidaroon; Napaporn Tananuvat; Chakree Hirunpat; Nauljira Prakairungthong; Wiwan Sansanayudh; Chareenun Chirapapaisan; Pakornkit Phrueksaudomchai
Journal:  JMIR Mhealth Uhealth       Date:  2022-06-22       Impact factor: 4.947

5.  Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.

Authors:  Amalia Enríquez-de-Salamanca; Evangelina Castellanos; Michael E Stern; Itziar Fernández; Ester Carreño; Carmen García-Vázquez; Jose M Herreras; Margarita Calonge
Journal:  Mol Vis       Date:  2010-05-19       Impact factor: 2.367

6.  Association of the Indoor Environment With Dry Eye Metrics.

Authors:  Amy Huang; Julia Janecki; Anat Galor; Sarah Rock; Dhariyat Menendez; Abigail S Hackam; Bennie H Jeng; Naresh Kumar
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

7.  Effectiveness of dry eye therapy under conditions of environmental stress.

Authors:  Alan Tomlinson; Louise C Madden; Peter A Simmons
Journal:  Curr Eye Res       Date:  2013-01-07       Impact factor: 2.424

8.  Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial.

Authors:  Michael A Patane; Amy Cohen; Stephen From; Gail Torkildsen; Donna Welch; George W Ousler
Journal:  Clin Ophthalmol       Date:  2011-05-15

9.  Prevalence of ocular surface disease symptoms and risk factors in group of university students in Monterrey, Mexico.

Authors:  Manuel Garza-León; Miguel Valencia-Garza; Bernardo Martínez-Leal; Pablo Villarreal-Peña; Hernán Gerardo Marcos-Abdala; Ana Lucía Cortéz-Guajardo; Arturo Jasso-Banda
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-11-18

10.  Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker.

Authors:  Fany Solange Usuba; Ana Cristina de Medeiros-Ribeiro; Priscila Novaes; Nadia Emi Aikawa; Karina Bonfiglioli; Ruth Miyuki Santo; Eloisa Bonfá; Milton Ruiz Alves
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.